Effects of genistein and daidzein on enhanced vascular contractile reactivity and Ca2+ sensitivity in cardiomyopathic hamsters

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 22, Issue 1, 2000, Pages 25-30

  Sato, A ^a   Hattori, Y ^a   Kanno, M ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Ca2+ sensitivity; Cardiomyopathic hamster; Tyrosine kinase; Vascular contractility

Indexed keywords

DAIDZEIN; GENISTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; CARDIOMYOPATHY; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HAMSTER; MESENTERIC ARTERY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; SKINNED MUSCLE FIBER; SMOOTH MUSCLE CONTRACTILITY; VASCULAR SMOOTH MUSCLE;

EID: 0034122776     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2000.22.1.795816     Document Type: Article

References (28)

1. Bajusz, E., Lossnitzer, K. A new disease model of chronic congestive heart failure: Studies on its pathogenesis: Trans NY Acad Sci 1968, 30: 939-48.
2. Strobeck, J.E., Factor, S.M., Bhan, A. et al. Hereditary and acquired cardiomyopathies in experimental animals: Mechanical, biochemical, and structural features. Ann NY Acad Sci 1979, 58: 59-85.
3. Factor, S.M., Cho, S., Scheuer, J., Sonnenblick, E.H., Malhotra, A. Prevention of hereditary cardiomyopathy in the Syrian hamster with chronic verapamil therapy. J Am Coll Cardiol 1988, 12: 1564-99.
4. Sole, M.J., Liew, C.C. Catecholamines, calcium and cardiomyopathy. Am J Cardiol 1988, 62: 20G-4.
5. Whitmer, J.T., Kumar, P., Solaro, R.J. Calcium transport properties of cardiac sacroplasmic reticulum from cardiomyopathic Syrian hamsters (BIO 53.58 and 14.6): Evidence for a quantitative defect in dilated myopathic hearts not evendent in hypertrophic hearts. Circ Res 1988, 62: 81-5.
6. 2+ sensitivity in enhanced vascular reactivity in cardiomyopathic hamster. Eur J Pharmacol 1998, 353: 247-56.
7. Dumont, E., Lambert, C., Lamontagne, D. Modification of aortic contractility in the cardiomyopathic hamster. Br J Pharmacol 1996, 118: 1141-6.
8. Hunter, E.G., Elbrink, J. Increased contractility in vascular smooth muscle of dystrophic hamsters. Can J Physiol Pharmacol 1982, 61: 182-5.
9. Fujiwara, T., Itoh, T., Kubota, Y., Kuriyama, H. Actions of a phorbol ester on factors regulating contraction in rabbit mesenteric artery. Circ Res 1988, 63: 893-902.
10. Chatterjee, M., Tejada, M. Phorbol ester-induced contraction in chemically skinned vascular smooth muscle. Am J Physiol 1986, 251: C356-61.
11. 2+ sensitivity in α-toxin-permeabilized rabbit mesenteric artery. Circ Res 1992, 71: 951-9.
12. RD Am J Physiol 1997, 272: C2019-30.
13. Myllarniemi, M., Calderon, L., Lemstrom, K., Buchdunger, E., Hayry, P. Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation. FASEB J 1997, 11: 1119-26.
14. Abebe, W., Agrawal, D.K. Role of tyrosine kinase in norepinephrine-induced contration of vascular smooth muscle. J Cardiovasc Pharmacol 1995, 26: 153-9.
15. Di Salvo, J., Steusloff, A., Semenchuk, L., Satoh, S., Kolquist, K., Pfitzer, G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun 1993, 190: 968-74.
16. Hollenberg, M.D. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 1994, 15: 108-14.
17. Filipeanu, C.M., Brailoiu, E., Huhurez, G., Slatineanu, S., Baltatu, O., Branisteanu, D.D. Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction. Eur J Pharmacol 1995, 281: 29-35.
18. Sun, C.W., Falck, J.R., Harder, D.R., Roman, R.J. Role of tyrosine kinase and PKC in the vascular response to 20-HETE in renal arterioles. Hypertension 1999, 33: 414-8.
19. Kutz, C., Paintz, M., Glusa, E. Inhibition of thrombin-induced contractile responses by protein kinase inhibitors in porcine pulmonary arteries. Exp Toxicol Pathol 1998, 50: 497-500.
20. Liu, C.Y., Sturek, M. Attenuation of endothelin-1-induced calcuim response by tyrosine kinase inhibitors in vascular smooth muscle cells. Am J Physiol 1996, 270: C1825-33.
21. 2+ sensitization of smooth muscle of rabbit mesenteric artery. Br J Pharmacol 1998, 125: 1651-60.
22. Ohanian, J., Ohanian, V., Shaw, L., Bruce, C., Heagerty, A.M. Involvement of tyrosine phosphorylation in endothelin-1-induced calcium-sensitization in rat small mesenteric arteries. Br J Pharmacol 1997, 120: 653-61.
23. Fukumoto, Y., Shimokawa, H., Kozai, T. et al. Tyrosine kinase inhibitor suppresses the (re) stenotic changes of the coronary artery after balloon injury in pigs. Cardiovasc Res 1996, 32: 1131-40.
24. Zerrouk, A., Auguet, M., Dabiré, H., Brisac, A-M., Safar, M., Chabrier, P-E. Differential effects of tyrosine kinase, inhibitors on contraction and relaxation of the aortae of normotensive and hypertensive rats. Eur J Pharmacol 1999, 374: 49-58.
25. Urasawa, K., Yoshida, I., Takagi, C. et al. Enhanced expression of β-adrenergic receptor kinase 1 in the hearts of cardiomyopathic Syrian hamsters, BIO 53.58. Biochem Biophys Res Commun 1996, 219: 26-30.
26. Sato, A., Hattori, Y., Watanabe, M. et al. Effect of prolonged treatment with amlodipine on enhanced vascular contractility in cardiomyopathic hamsters. J Cardiovasc Pharmacol 1999, 34: 124-31.
27. Akiyama, T., Ishida, J., Nakagawa, S. et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987, 262: 5592-5.
28. 2+ sensitivity in α-toxin permeabilized arterial smooth muscle. Biochem Biophys Res Commun 1988, 157: 677-83.